Potassium binder

This page covers all Potassium binder drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium ion (K+) in gastrointestinal lumen, Potassium ion (K+) in gastrointestinal tract.

Targets

Potassium ion (K+) in gastrointestinal lumen · Potassium ion (K+) in gastrointestinal tract

Marketed (4)

• Patiromer Oral Product · Wake Forest University Health Sciences · Cardiovascular
  Patiromer is a non-absorbed potassium binder that sequesters potassium in the gastrointestinal tract to reduce serum potassium levels.
• sodium zirconium cyclic silicate · Peking University First Hospital · Nephrology / Cardiology
  Sodium zirconium cyclic silicate is a non-absorbed potassium binder that traps potassium in the gastrointestinal tract through ion exchange, reducing serum potassium levels.
• Zirconium Cyclosilicate · AstraZeneca · Cardiovascular
  Zirconium cyclosilicate is a non-absorbed potassium binder that traps potassium in the gastrointestinal tract and increases fecal potassium excretion.
• LOKELMA 5 GM Powder for Oral Suspension · Steno Diabetes Center Copenhagen · Nephrology / Cardiology
  Lokelma (sodium zirconium cyclosilicate) is a potassium binder that traps potassium in the gastrointestinal tract and increases fecal potassium excretion.

Phase 3 pipeline (1)

• Lokelma Oral Product · St George's, University of London · Cardiovascular
  Lokelma is a potassium binder that selectively captures and removes potassium from the gastrointestinal tract to lower serum potassium levels.